Stock Quote
deCODE genetics, Inc. (DCGN.W) (NASD ADF)
$0.04
20 Nov 2009
+8.57%
$0.04
$0.04
30,000
$0.04
$0.04
$0.94
$0.03
1.11
4,350,371
DCGN.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Stefansson, Kari | Chairman of the Board, President, Chief Executive Officer | 1,116,550 |
| Thibault, Lance | Chief Financial Officer, Treasurer | 450,708 |
| Nielsen, Axel | Chief Operating Officer | 762,313 |
Profile
deCODE genetics, Inc. (deCODE) is a bio-pharmaceutical company developing and marketing products for the treatment, diagnosis, and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in therapeutic areas, and applies its... Full Description
Company Address
deCODE genetics, Inc.
Sturlugata 8
IS-101
Iceland
Reykjavik
Sturlugata 8
IS-101
Iceland
Reykjavik
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Roche Holding Ltd. | CHF166.20 | +3.50 |
| Roche Holding Ltd. | CHF169.10 | +1.80 |
| Merck Limited | Rs561.05 | +0.55 |
| DCGN.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 0.07 | 29.90 |
| ROI(TTM) | -104.53 | 2.35 |
| ROE(TTM) | -- | 3.59 |
| Consensus Recommendation | |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $3.50M |
| Net Income | $-12.13M |
| EPS | $-0.20 |
